Evidence map›Paper›PMID 38586343›Full record

ArticleHeliyon2024

The effect of

Ezgi Paslı Uysalol, Metin Uysalol, Istemi Serin, Mustafa Pehlivan, Yasemin Oyaci, Sacide Pehlivan, Zeynep Karakas

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ezgi Paslı UysalolBasaksehir Cam and Sakura City Hospital, Department of Pediatric Hematology- Oncology, Turkey.
Metin UysalolIstanbul University, Istanbul Faculty of Medicine, Department of Pediatrics, Division of Pediatric Emergency, Turkey.
Istemi SerinAgri Training and Research Hospital, Department of Hematology, Turkey.
Mustafa PehlivanBasaksehir Cam and Sakura City Hospital, Department of Hematology, Turkey.
Yasemin OyaciIstanbul University, Istanbul Faculty of Medicine, Department of Medical Biology and Genetics, Turkey.
Sacide PehlivanIstanbul University, Istanbul Faculty of Medicine, Department of Medical Biology and Genetics, Turkey.
Zeynep KarakasIstanbul University, Istanbul Faculty of Medicine, Department of Pediatric Hematology- Oncology, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aim: Leptin is mainly produced in adipose tissue and released into systemic circulation. Leptin and its receptor LEPR activate the Janus kinase/signal transducers and activators of transcription signaling cascade and increase cytokine discharge. In our study, we aimed to examine the role of Methods: This study included pediatric patients with a diagnosis of malignancy who applied to the pediatric emergency department between December 2019 and June 2022 and healthy controls. The genotypes of the Results: In the statistical analysis in terms of Conclusions: It was revealed that leptin gene polymorphisms did not have a significant effect during the course of FEN.

Indexed as

AdipokineFebrile neutropeniaLeptinPrognosis

Identifiers

PMID38586343
PMCPMC10998141

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.